D

Boston Scientific Corporation BSX

$43.34 -$0.21-0.48% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Boston Scientific Corporation is a global medical technology company that designs, manufactures, and markets medical devices used in a wide range of minimally invasive interventional medical specialties. The company operates primarily within the medical devices and healthcare technology industries, focusing on improving patient outcomes while reducing procedural complexity and healthcare costs. Its products are used by physicians and healthcare providers to diagnose and treat complex conditions across cardiovascular, rhythm management, endoscopy, urology, neuromodulation, and oncology care pathways.

The company’s core revenue is driven by its Cardiovascular, Rhythm and Neuro, and MedSurg business segments, which together cover implantable devices, catheters, stents, endoscopic tools, and neuromodulation systems. Boston Scientific serves hospitals, outpatient centers, and specialized clinics globally, with a strategic advantage in its broad product portfolio, strong clinical evidence base, and consistent investment in research and development. Founded in 1979 and publicly listed in 1992, Boston Scientific evolved through organic innovation and targeted acquisitions into one of the world’s largest pure-play medical device companies.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Monday, August 3, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 2 and 6 (est)

Price History

Loading...
52-Week Range2% of range
Low
$42.20
Current
$43.34
High
$105.65
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
508 683 4000
Address
300 Boston Scientific Way
Marlborough, MA 01752-1234
Country
Year Founded

Headlines

9/16/2026 - Zacks Investment Research